What Exactly is Neuropathy?

In the United States, about 20 million people are suffering from something called neuropathy. So, what is it exactly? It’s a collection of disorders that happen when the nerves outside of your brain and spinal cord are damaged; this is typically called peripheral neuropathy. It can affect nerves that control how you move and even those that control the sensations you feel, like coldness or pain. It also interferes with internal organs, such as your heart, bladder, or intestines.

What Exactly is Neuropathy?

If you think you may be suffering from neuropatthy, you’re most likely feeling a tingling pain or burning sensation, which can be treated with the help of some remedies or medical food, such as Neurvasia.

These pains don’t exactly have a specific time that they last, though. To get to the underlying cause of this, you have to take a few things into consideration, such as your diet, any diseases you have, or trauma. However, many cases have shown to have no known reason to cause it.

Peripheral neuropathy can be broadly classified into the 3 different categories:

  1. Mononeuropathy which involves just a single nerve.
  2. Multiple mononeuropathy  in which two or more nerves are affected.
  3. Polyneuropathy which generally affects just the peripheral nerves.

Neurophathies can also be classified by the functions it interferes with, such as motor, sensory, autonomic, or mixed, or the length of time it lasts. Acute meaning hours or days, subacute meaning weeks or months, and chronic meaning months or years. Probably the most common form of n europathy is peripheral polyneuropathy, which impacts the feet and legs on both sides of the body.

Enhanced by Zemanta

Prevention of cardiac autonomic neuropathy in dogs with Benfotiamine.

Source: www.benfotiamine.org

So far so good.

! That is why we pay attention to the quality of the medications.

Prevention of cardiac autonomic neuropathy in dogs with Benfotiamine.


Koltai MZ.
In Gries FA, Federlin K.

Benfotiamin in the Therapy of Polyneuropathy.
New York: Georg Thieme Verlag, 1998; 45-9.

Experimentally-induced diabetes of the dog leads to disturbances in the autonomous neurological function of the heart after approximately 3 months of continuously- observed diabetes. As signs of autonomic cardiac neuropathy, the heart rate variability and Valsalva ratio clearly fell in the untreated diabetic animals. Oral benfotiamine, administered from the sixth day after diabetes-induction, prevented or at least delayed these changes. According to the results, treatment with fat-soluble benfotiamine can play an important role in the therapy and prevention of cardiac autonomic neuropathy, apart from any effect on diabetic metabolic

Enhanced by Zemanta